Phytoecdysteroids and vitamin d analogues - similarities in structure and mode of action

Current Medicinal Chemistry

Volumn 17, Issue 18, 2010, Pages 1974-1994

  Tóth, Noémi ^a   Hunyadi, Attila ^a   Báthori, Mária ^a   Zádor, Erno ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Alternative ligand binding pocket; Conformational ensemble model; Ecdysteroid; Vitamin d analogues; Vitamin d receptor

Indexed keywords

CALCIFEDIOL; CALCITRIOL; CELL NUCLEUS RECEPTOR; CYTOPLASMIC RECEPTOR; ECDYSONE; ECDYSTEROID; MEMBRANE RECEPTOR; PHYTOSTEROL; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR; VITAMIN RECEPTOR;

ANDROGENESIS; ARTHROPOD; ARTICLE; CHEMICAL MODIFICATION; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; DRUG STRUCTURE; GENETIC TRANSCRIPTION; GENOMICS; LIGAND BINDING; MOLECULAR DOCKING; MORPHOLOGY; MUSCLE FUNCTION; MUSCLE STRENGTH; NONHUMAN; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; STRUCTURE ACTIVITY RELATION; VITAMIN D DEFICIENCY;

ANIMALS; ECDYSTEROIDS; HUMANS; MODELS, MOLECULAR; VITAMIN D;

EID: 77953516303     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710791163911     Document Type: Article

References (148)

1. Bathori, M.; Toth, N.; Hunyadi, A.; Marki, A.; Zador, E. Phytoecdysteroids and anabolic-androgenic steroids--structure and effects on humans. Curr. Med. Chem., 2008, 15, 75-91.
2. Henry, H. L.; Norman, A. W. Studies on calciferol metabolism. IX. Renal 25-hydroxy-vitamin D3-1 hydroxylase. Involvement of cytochrome P-450 and other properties. J. Biol. Chem., 1974, 249, 7529-7535.
3. Bikle, D. D.; Rasmussen, H. The ionic control of 1,25- dihydroxyvitamin D3 production in isolated chick renal tubules. J. Clin. Invest., 1975, 55, 292-298.
4. Goltzman, D.; Miao, D.; Panda, D. K.; Hendy, G. N. Effects of calcium and of the Vitamin D system on skeletal and calcium homeostasis: lessons from genetic models. J. Steroid Biochem. Mol. Biol., 2004, 89-90, 485-489.
5. Chlon, T. M.; Taffany, D. A.; Welsh, J.; Rowling, M. J. Retinoids modulate expression of the endocytic partners megalin, cubilin, and disabled-2 and uptake of vitamin D-binding protein in human mammary cells. J. Nutr., 2008, 138, 1323-1328.
6. [6] Norman, A. W. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am. J. Clin. Nutr., 2008, 88, 491S-499S.
7. Curino, A.; Milanesi, L.; Benassati, S; Skliar, M.; Boland R. Effect of culture conditions on the synthesis of vitamin D(3) metabolites in Solanum glaucophyllum grown in vitro. Phytochemistry. 2001, 58, 81-89.
8. Curino, A.; Skliar, M.; Boland, R. Identification of 7- dehydrocholesterol, vitamin D3, 25(OH)-vitamin D3 and 1,25(OH)2-vitamin D3 in Solanum glaucophyllum cultures grown in absence of light. Biochim. Biophys. Acta, 1998, 1425, 485-492.
9. Adler, J. H.; Grebenok, R. J. Occurrence, biosynthesis, and putative role of ecdysteroids in plants. Crit. Rev. Biochem. Mol. Biol., 1999, 34, 253-264.
10. Canals, D.; Irurre-Santilari, J.; Casas, J. The first cytochrome P450 in ferns. Evidence for its involvement in phytoecdysteroid biosynthesis in Polypodium vulgare. FEBS J., 2005, 272, 4817-4825.
11. Grebenok, R. J.; Galbraith, D. W.; Benveniste, I.; Feyereisen, R. Ecdysone 20-monooxygenase, a cytochrome P450 enzyme from spinach, Spinacia oleracea. Phytochemistry, 1996, 42, 927-933.
12. Alekseeva, L. I. Ecdysone 20-monooxygenase activity of cytochrome P450 in plants and cell culture of Ajuga reptans L. Prikl. Biokhim. Mikrobiol., 2004, 40, 159-164.
13. Bakrim, A.; Guittard, E.; Maria, A.; De Virville, J. D.; Lafont, R.; Takvorian, N. Phytoecdysteroid C2-hydroxylase is microsomal in spinach, Spinacia oleracea L. Arch. Insect Biochem. Physiol, 2009, 72, 210-219.
14. Okamura, W. H.; Midland, M. M.; Hammond, M. W.; Abd, R. N.; Dormanen, M. C.; Nemere, I.; Norman, A. W. Chemistry and conformation of vitamin D molecules. J. Steroid Biochem. Mol. Biol., 1995, 53, 603-613.
15. Henry, H. L. Vitamin D hydroxylases. J. Cell Biochem., 1992, 49, 4-9.
16. Bouillon, R.; Okamura, W. H.; Norman, A. W. Structure-function relationships in the vitamin D endocrine system. Endocr. Rev., 1995, 16, 200-257.
17. Pis, J.; Vaisar, T. H/D isotopic exchange in the fast atom bombardment of ecdysteroids. J. Mass Spectrometry, 1997, 32, 1050-1056.
18. Vaisar, T.; Pis, J. Cyclic boronates in the mass-spectrometry of ecdysteroids. Rapid Commun. Mass-Spectrometry, 1993, 7, 46-52.
19. Evans, R. M. The steroid and thyroid hormone receptor superfamily. Science, 1988, 240, 889-895.
20. Mangelsdorf, D. J.; Thummel, C.; Beato, M.; Herrlich, P.; Schutz, G.; Umesono, K.; Blumberg, B.; Kastner, P.; Mark, M.; Chambon, P.; Evans, R. M. The nuclear receptor superfamily: the second decade. Cell, 1995, 83, 835-839.
21. Sutton, A. L.; Macdonald, P. N. Vitamin D: more than a bone-a- fide hormone. Mol. Endocrinol., 2003, 17, 777-791.
22. Weatherman, R. V.; Fletterick, R. J.; Scanlan, T. S. Nuclearreceptor ligands and ligand-binding domains. Annu. Rev. Biochem., 1999, 68, 559-581.
23. Zhang, X. K.; Lehmann, J.; Hoffmann, B.; Dawson, M. I.; Cameron, J.; Graupner, G.; Hermann, T.; Tran, P.; Pfahl, M. Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid. Nature, 1992, 358, 587-591.
24. Billas, I. M.; Moras, D. Ligand-binding pocket of the ecdysone receptor. Vitam. Horm., 2005, 73, 101-129.
25. Nemere, I.; Hintze, K. Novel hormone receptors. J. Cell Biochem., 2008, 103, 401-407.
26. [26] Mizwicki, M. T.; Norman, A. W. The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling. Sci. Signal., 2009, 2, re4.
27. Nemere, I.; Farach-Carson, M. C.; Rohe, B.; Sterling, T. M.; Norman, A. W.; Boyan, B. D.; Safford, S. E. Ribozyme knockdown functionally links a 1,25(OH)2D3 membrane binding protein (1,25D3-MARRS) and phosphate uptake in intestinal cells. Proc. Natl. Acad. Sci. U. S. A, 2004, 101, 7392-7397.
28. Nemere, I. The 1,25D3-MARRS protein: contribution to steroid stimulated calcium uptake in chicks and rats. Steroids, 2005, 70, 455-457.
29. Nemere, I.; Hintze, K. Novel hormone receptors. J. Cell Biochem., 2008, 103, 401-407.
30. Rochel, N.; Wurtz, J. M.; Mitschler, A.; Klaholz, B.; Moras, D. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol. Cell, 2000, 5, 173-179.
31. Rochel, N.; Tocchini-Valentini, G.; Egea, P. F.; Juntunen, K.; Garnier, J. M.; Vihko, P.; Moras, D. Functional and structural characterization of the insertion region in the ligand binding domain of the vitamin D nuclear receptor. Eur. J. Biochem., 2001, 268, 971-979.
32. Wurtz, J. M.; Guillot, B.; Fagart, J.; Tietjen, K.; Schindler, M. A new model for 20-hydroxyecdysone and dibenzoylhydrazine binding: A homology modeling and docking approach. Protein Science, 2000, 9, 1073-1084.
33. Billas, I. M.; Iwema, T.; Garnier, J. M.; Mitschler, A.; Rochel, N.; Moras, D. Structural adaptability in the ligand-binding pocket of the ecdysone hormone receptor. Nature, 2003, 426, 91-96.
34. Losel, R. M.; Falkenstein, E.; Feuring, M.; Schultz, A.; Tillmann, H. C.; Rossol-Haseroth, K.; Wehling, M. Nongenomic steroid action: controversies, questions, and answers. Physiol. Rev., 2003, 83, 965-1016.
35. Schlattner, U.; Vafopoulou, X.; Steel, C. G.; Hormann, R. E.; Lezzi, M. Non-genomic ecdysone effects and the invertebrate nuclear steroid hormone receptor EcR--new role for an old receptor? Mol. Cell Endocrinol., 2006, 247, 64-72.
36. Huhtakangas, J. A.; Olivera, C. J.; Bishop, J. E.; Zanello, L. P.; Norman, A. W. The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha,25(OH)2-vitamin D3 in vivo and in vitro. Mol. Endocrinol., 2004, 18, 2660-2671.
37. Tishkoff, D. X.; Nibbelink, K. A.; Holmberg, K. H.; Dandu, L.; Simpson, R. U. Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. Endocrinology, 2008, 149, 558-564.
38. Norman, A. W.; Okamura, W. H.; Hammond, M. W.; Bishop, J. E.; Dormanen, M. C.; Bouillon, R.; van, B. H.; Ridall, A. L.; Daane, E.; Khoury, R.; Farach-Carson, M. C. Comparison of 6-s-cis- and 6-s-trans-locked analogs of 1alpha,25-dihydroxyvitamin D3 indicates that the 6-s-cis conformation is preferred for rapid nongenomic biological responses and that neither 6-s-cis- nor 6-s- trans-locked analogs are preferred for genomic biological responses. Mol. Endocrinol., 1997, 11, 1518-1531.
39. Mizwicki, M. T.; Keidel, D.; Bula, C. M.; Bishop, J. E.; Zanello, L. P.; Wurtz, J. M.; Moras, D.; Norman, A. W. Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1alpha,25(OH)2-vitamin D3 signaling. Proc. Natl. Acad. Sci. U. S. A, 2004, 101, 12876-12881.
40. Mizwicki, M. T.; Bishop, J. E.; Norman, A. W. Applications of the Vitamin D sterol-Vitamin D receptor (VDR) conformational ensemble model. Steroids, 2005, 70, 464-471.
41. Wagner, R. L.; Apriletti, J. W.; McGrath, M. E.; West, B. L.; Baxter, J. D.; Fletterick, R. J. A structural role for hormone in the thyroid hormone receptor. Nature, 1995, 378, 690-697.
42. Renaud, J. P.; Rochel, N.; Ruff, M.; Vivat, V.; Chambon, P.; Gronemeyer, H.; Moras, D. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature, 1995, 378, 681-689.
43. Norman, A. W.; Mizwicki, M. T.; Norman, D. P. Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat. Rev. Drug Discov., 2004, 3, 27-41.
44. Egea, P. F.; Mitschler, A.; Rochel, N.; Ruff, M.; Chambon, P.; Moras, D. Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid. EMBO J., 2000, 19, 2592-2601.
45. Egea, P. F.; Klaholz, B. P.; Moras, D. Ligand-protein interactions in nuclear receptors of hormones. FEBS Lett., 2000, 476, 62-67.
46. Carlsson, P.; Burendahl, S.; Nilsson, L. Unbinding of retinoic acid from the retinoic acid receptor by random expulsion molecular dynamics. Biophys. J., 2006, 91, 3151-3161.
47. Perakyla, M. Ligand unbinding pathways from the vitamin D receptor studied by molecular dynamics simulations. Eur. Biophys. J., 2009, 38, 185-198.
48. Soisson, S. M.; Parthasarathy, G.; Adams, A. D.; Sahoo, S.; Sitlani, A.; Sparrow, C.; Cui, J.; Becker, J. W. Identification of a potent synthetic FXR agonist with an unexpected mode of binding and activation. Proc. Natl. Acad. Sci. U. S. A, 2008, 105, 5337-5342.
49. van Hoorn, W. P. Identification of a second binding site in the estrogen receptor. J. Med. Chem., 2002, 45, 584-589.
50. Bursavich, M. G.; Rich, D. H. Designing non-peptide peptidomimetics in the 21st century: inhibitors targeting conformational ensembles. J. Med. Chem., 2002, 45, 541-558.
51. Dreier, R.; Gunther, B. K.; Mainz, T.; Nemere, I.; Bruckner, P. Terminal differentiation of chick embryo chondrocytes requires shedding of a cell surface protein that binds 1,25-dihydroxyvitamin D3. J. Biol. Chem., 2008, 283, 1104-1112
52. Ceglia, L. Vitamin D and skeletal muscle tissue and function. Mol. Aspects Med., 2008, 29, 407-414.
53. Boland, R. Role of vitamin D in skeletal muscle function. Endocr. Rev., 1986, 7, 434-448.
54. Ritz, E.; Boland, R.; Kreusser, W. Effects of vitamin D and para- thyroid hormone on muscle: potential role in uremic myopathy. Am. J. Clin. Nutr., 1980, 33, 1522-1529.
55. Ekbom, K.; Hed, R.; Kirstein, L.; Astroem, K. E. Weakness of proximal limb muscles, probably due to myopathy after partial gastrectomy. Preliminary report. Acta Med. Scand., 1964, 176, 493-496.
56. Smith, R.; Stern, G. Myopathy, osteomalacia and hyperparathyroidism. Brain, 1967, 90, 593-602.
57. Pfeifer, M.; Begerow, B.; Minne, H. W. Vitamin D and muscle function. Osteoporos. Int., 2002, 13, 187-194.
58. Montgomery, J. L.; King, M. B.; Gentry, J. G.; Barham, A. R.; Barham, B. L.; Hilton, G. G.; Blanton, J. R., Jr.; Horst, R. L.; Galyean, M. L.; Morrow, K. J., Jr.; Wester, D. B.; Miller, M. F. Supplemental vitamin D3 concentration and biological type of steers. II. Tenderness, quality, and residues of beef. J. Anim. Sci., 2004, 82, 2092-2104.
59. Simpson, R. U.; Thomas, G. A.; Arnold, A. J. Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. J. Biol. Chem., 1985, 260, 8882-8891.
60. Costa, E. M.; Blau, H. M.; Feldman, D. 1,25-dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells. Endocrinology, 1986, 119, 2214-2220.
61. Zanello, S. B.; Collins, E. D.; Marinissen, M. J.; Norman, A. W.; Boland, R. L. Vitamin D receptor expression in chicken muscle tissue and cultured myoblasts. Horm. Metab. Res., 1997, 29, 231-236.
62. Endo, I.; Inoue, D.; Mitsui, T.; Umaki, Y.; Akaike, M.; Yoshizawa, T.; Kato, S.; Matsumoto, T. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology, 2003, 144, 5138-5144.
63. Bischoff, H. A.; Borchers, M.; Gudat, F.; Duermueller, U.; Theiler, R.; Stahelin, H. B.; Dick, W. In situ detection of 1,25- dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem. J., 2001, 33, 19-24.
64. Eelen, G.; Gysemans, C.; Verlinden, L.; Vanoirbeek, E.; De Clercq, P. Van Haver, D.; Mathieu, C.; Bouillon, R.; Verstuyf, A. Mechanism and potential of the growth-inhibitory actions of vitamin D and analogs. Curr. Med. Chem. 2007, 14, 1893-910.
65. Savkur, R. S.; Bramlett, K. S.; Stayrook, K. R.; Nagpal, S.; Burris, T. P. Coactivation of the human vitamin D receptor by the peroxisome proliferator-activated receptor gamma coactivator-1 alpha. Mol. Pharmacol., 2005, 68, 511-517.
66. Wu, Z.; Puigserver, P.; Andersson, U.; Zhang, C.; Adelmant, G.; Mootha, V.; Troy, A.; Cinti, S.; Lowell, B.; Scarpulla, R. C.; Spiegelman, B. M. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell, 1999, 98, 115-124.
67. Nemere, I.; Yoshimoto, Y.; Norman, A. W. Calcium transport in perfused duodena from normal chicks: enhancement within fourteen minutes of exposure to 1,25-dihydroxyvitamin D3. Endocrinology, 1984, 115, 1476-1483.
68. de Boland, A. R.; Nemere, I. Rapid actions of vitamin D compounds. J. Cell Biochem., 1992, 49, 32-36.
69. Nemere, I.; Zhou, L. X.; Norman, A. W. Nontranscriptional effects of steroid hormones. Receptor, 1993, 3, 277-291.
70. Baran, D. T.; Sorensen, A. M. Rapid actions of 1 alpha-25- dihydroxyvitamin D3 physiologic role. Proc. Soc. Exp. Biol. Med., 1994, 207, 175-179.
71. Facchinetti, M. M.; Boland, R.; de Boland, A. R. Calcitriol transmembrane signalling: regulation of rat muscle phospholipase D activity. J. Lipid Res., 1998, 39, 197-204.
72. Facchinetti, M. M.; Boland, R.; de Boland, A. R. Age-related loss of calcitriol stimulation of phosphoinositide hydrolysis in rat skeletal muscle. Mol. Cell Endocrinol., 1998, 136, 131-138.
73. Facchinetti, M. M.; de Boland, A. R. Effect of ageing on the expression of protein kinase C and its activation by 1,25(OH)2- vitamin D3 in rat skeletal muscle. Cell Signal., 1999, 11, 39-44.
74. Buitrago, C. G.; Ronda, A. C.; de Boland, A. R.; Boland, R. MAP kinases p38 and JNK are activated by the steroid hormone 1alpha,25(OH)2-vitamin D3 in the C2C12 muscle cell line. J. Cell Biochem., 2006, 97, 698-708.
75. Zhou, Q. G.; Hou, F. F.; Guo, Z. J.; Liang, M.; Wang, G. B.; Zhang, X. 1,25-Dihydroxyvitamin D improved the free fatty-acid- induced insulin resistance in cultured C2C12 cells. Diabetes Metab. Res. Rev., 2008, 24, 459-464.
76. Mathieu, C.; Gysemans, C.; Giulietti, A.; Bouillon, R. Vitamin D and diabetes. Diabetologia, 2005, 48, 1247-1257.
77. Sahach, V. F.; Korkach, I.; Kotsiuruba, A. V.; Rudyk, O. V.; Vavilova, H. L. Mitochondrial permeability transition pore opening inhibition by ecdysterone in heart mitochondria of aging rats. Fiziol. Zh., 2008, 54, 3-10.
78. Oehme, I.; Bosser, S.; Zornig, M. Agonists of an ecdysone-inducible mammalian expression system inhibit Fas Ligand- and TRAIL-induced apoptosis in the human colon carcinoma cell line RKO. Cell Death. Differ., 2006, 13, 189-201.
79. Kizelsztein, P.; Govorko, D.; Komarnytsky, S.; Evans, A.; Wang, Z.; Cefalu, WT.; Raskin, I. 20-Hydroxyecdysone decreases weight and hyperglycemia in a diet-induced obesity mice model. Am. J. Physiol. Endocrinol. Metab., 2009, 296, E433-439.
80. Ronda, A. C.; Buitrago, C.; Colicheo, A.; de Boland, A. R.; Roldan, E.; Boland, R. Activation of MAPKs by 1alpha,25(OH)2- Vitamin D3 and 17beta-estradiol in skeletal muscle cells leads to phosphorylation of Elk-1 and CREB transcription factors. J. Steroid Biochem. Mol. Biol., 2007, 103, 462-466.
81. Estrada, M.; Espinosa, A.; Gibson, C. J.; Uhlen, P.; Jaimovich, E. Capacitative calcium entry in testosterone-induced intracellular calcium oscillations in myotubes. J. Endocrinol., 2005, 184, 371-379.
82. Parekh, A. B.; Putney, J. W., Jr. Store-operated calcium channels. Physiol. Rev., 2005, 85, 757-810.
83. Santillan, G.; Baldi, C.; Katz, S.; Vazquez, G.; Boland, R. Evidence that TRPC3 is a molecular component of the 1alpha,25(OH)2D3- activated capacitative calcium entry (CCE) in muscle and os-teoblast cells. J. Steroid Biochem. Mol. Biol., 2004, 89-90, 291-295.
84. Santillan, G.; Katz, S.; Vazquez, G.; Boland, R. L. TRPC3-like protein and vitamin D receptor mediate 1alpha,25(OH)2D3- induced SOC influx in muscle cells. Int. J. Biochem. Cell Biol., 2004, 36, 1910-1918.
85. Mizwicki, M. T.; Bula, C. M.; Bishop, J. E.; Norman, A. W. New insights into Vitamin D sterol-VDR proteolysis, allostery, structure-function from the perspective of a conformational ensemble model. J. Steroid Biochem. Mol. Biol., 2007, 103, 243-262.
86. Olivera, C. J.; Bula, C. M.; Bishop, J. E.; Adorini, L.; Manchand, P.; Uskokovic, M. R.; Norman, A. W. Characterization of five 19- nor-analogs of 1alpha,25(OH)2-Vitamin D3 with 20-cyclopropyl- modified side-chains: implications for ligand binding and calcemic properties. J. Steroid Biochem. Mol. Biol., 2004, 89-90, 99-106.
87. Harant, H.; Spinner, D.; Reddy, G. S.; Lindley, I. J. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor. J. Cell Biochem., 2000, 78, 112-120.
88. Rao, D. S.; Campbell, M. J.; Koeffler, H. P.; Ishizuka, S.; Uskokovic, M. R.; Spagnuolo, P.; Reddy, G. S. Metabolism of 1alpha,25-dihydroxyvitamin D(3) in human promyelocytic leukemia (HL-60) cells: in vitro biological activities of the natural metabolites of 1alpha,25-dihydroxyvitamin D(3) produced in HL- 60 cells. Steroids, 2001, 66, 423-431.
89. Ozono, K.; Saito, M.; Miura, D.; Michigami, T.; Nakajima, S.; Ishizuka, S. Analysis of the molecular mechanism for the antagonistic action of a novel 1alpha,25-dihydroxyvitamin D(3) analogue toward vitamin D receptor function. J. Biol. Chem., 1999, 274, 32376-32381.
90. Ishizuka, S.; Miura, D.; Eguchi, H.; Ozono, K.; Chokki, M.; Kamimura, T.; Norman, A. W. Antagonistic action of novel 1alpha,25-dihydroxyvitamin D(3)-26, 23-lactone analogs on 25- hydroxyvitamin-D(3)-24-hydroxylase gene expression induced by 1alpha,25-dihydroxy-vitamin D(3) in human promyelocytic leukemia (HL-60) cells. Arch. Biochem. Biophys., 2000, 380, 92-102.
91. Miura, D.; Manabe, K.; Gao, Q.; Norman, A. W.; Ishizuka, S. 1alpha,25-dihydroxyvitamin D(3)-26,23-lactone analogs antagonize differentiation of human leukemia cells (HL-60 cells) but not of human acute promyelocytic leukemia cells (NB4 cells). FEBS Lett., 1999, 460, 297-302.
92. Yoshimoto, Y.; Nemere, I.; Norman, A. W. Hypercalcemia inhibits the rapid stimulatory effect on calcium transport in perfused duodena from normal chicks mediated in vitro by 1,25- dihydroxyvitamin D3. Endocrinology, 1986, 118, 2300-2304.
93. Zanello, L. P.; Norman, A. W. Stimulation by 1alpha,25(OH)2- vitamin D3 of whole cell chloride currents in osteoblastic ROS 17/2.8 cells. A structure-function study. J. Biol. Chem., 1997, 272, 22617-22622.
94. Khoury, R.; Ridall, A. L.; Norman, A. W.; Farach-Carson, M. C. Target gene activation by 1,25-dihydroxyvitamin D3 in osteosarcoma cells is independent of calcium influx. Endocrinology, 1994, 135, 2446-2453.
95. Mizwicki, M. T.; Bula, C. M.; Bishop, J. E.; Norman, A. W. A perspective on how the Vitamin D sterol/Vitamin D receptor (VDR) conformational ensemble model can potentially be used to understand the structure-function results of A-ring modified Vitamin D sterols. J. Steroid Biochem. Mol. Biol., 2005, 97, 69-82.
96. Miura, D.; Norman, A. W.; Mizwicki, M. T.; Fujishima, T.; Konno, K.; Kittaka, A.; Takayama, H.; Ishizuka, S. The antagonism between 2-methyl-1,25-dihydroxyvitamin D3 and 2-methyl-20-epi- 1,25-dihydroxyvitamin D3 in non-genomic pathway-mediated biological responses induced by 1alpha,25-dihydroxyvitamin D3 assessed by NB4 cell differentiation. J. Steroid Biochem. Mol. Biol., 2005, 94, 469-479.
97. Norman, A. W.; Okamura, W. H.; Farach-Carson, M. C.; Allewaert, K.; Branisteanu, D.; Nemere, I.; Muralidharan, K. R.; Bouillon, R. Structure-function studies of 1,25-dihydroxyvitamin D3 and the vitamin D endocrine system. 1,25-dihydroxy- pentadeuterio-previtamin D3 (as a 6-s-cis analog) stimulates nongenomic but not genomic biological responses. J. Biol. Chem., 1993, 268, 13811-13819.
98. Wecksler, W. R.; Norman, A. W. An hydroxylapatite batch assay for the quantitation of 1alpha,25-dihydroxyvitamin D3-receptor complexes. Anal. Biochem., 1979, 92, 314-323.
99. Sheves, M.; Friedman, N.; Mazur, Y. Conformational equilibria in vitamin D. Synthesis of 1beta-hydroxyvitamin D3. J. Org. Chem., 1977, 42, 3597-3599.
100. Sheves, M.; Berman, E.; Freeman, D.; Mazur, Y. Conformational equilibria in vitamins D. The synthesis of 1alpha-hydroxy-3- epivitamin D3 (1alpha-hydroxy-3alpha-cholecalciferol). J. Chem. Soc., Chem. Commun., 1975, 511, 643-644.
101. Konno, K.; Fujishima, T.; Maki, S.; Liu, Z.; Miura, D.; Chokki, M.; Ishizuka, S.; Yamaguchi, K.; Kan, Y.; Kurihara, M.; Miyata, N.; Smith, C.; DeLuca, H. F.; Takayama, H. Synthesis, biological evaluation, and conformational analysis of A-ring diastereomers of 2-methyl-1,25-dihydroxyvitamin D(3) and their 20-epimers: unique activity profiles depending on the stereochemistry of the A-ring and at C-20. J. Med. Chem., 2000, 43, 4247-4265.
102. Kamao, M.; Tatematsu, S.; Hatakeyama, S.; Sakaki, T.; Sawada, N.; Inouye, K.; Ozono, K.; Kubodera, N.; Reddy, G. S.; Okano, T. C-3 epimerization of vitamin D3 metabolites and further metabolism of C-3 epimers: 25-hydroxyvitamin D3 is metabolized to 3-epi-25-hydroxyvitamin D3 and subsequently metabolized through C-1alpha or C-24 hydroxylation. J. Biol. Chem., 2004, 279, 15897-15907.
103. Konno, K.; Fujishima, T.; Maki, S.; Liu, Z.; Miura, D.; Chokki, M.; Ishizuka, S.; Yamaguchi, K.; Kan, Y.; Kurihara, M.; Miyata, N.; Smith, C.; DeLuca, H. F.; Takayama, H. Synthesis, biological evaluation, and conformational analysis of A-ring diastereomers of 2-methyl-1,25-dihydroxyvitamin D(3) and their 20-epimers: unique activity profiles depending on the stereochemistry of the A-ring and at C-20. J. Med. Chem., 2000, 43, 4247-4265.
104. Saito, N.; Matsunaga, T.; Fujishima, T.; Anzai, M.; Saito, H.; Takenouchi, K.; Miura, D.; Ishizuka, S.; Takayama, H.; Kittaka, A. Remarkable effect of 2 [small alpha]-modification on the VDR antagonistic activity of 1small alpha-hydroxyvitamin D3-26,23- lactones. Org. Biomol. Chem., 2003, 1, 4396-4402.
105. Konno, K.; Maki, S.; Fujishima, T.; Liu, Z.; Miura, D.; Chokki, M.; Takayama, H. A novel and practical route to A-ring enyne synthon for 1 alpha,25-dihydroxyvitamin D3 analogs: synthesis of A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D2 and 3-methyl- 1,25-dihydroxyvitamin D3. Bioorg. Med. Chem. Lett., 1998, 8, 151-156.
106. Brown, A. J.; Ritter, C.; Slatopolsky, E.; Muralidharan, K. R.; Okamura, W. H.; Reddy, G. S. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion. J. Cell Biochem., 1999, 73, 106-113.
107. Norman, A. W.; Bouillon, R.; Farach-Carson, M. C.; Bishop, J. E.; Zhou, L. X.; Nemere, I.; Zhao, J.; Muralidharan, K. R.; Okamura, W. H. Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3. J. Biol. Chem., 1993, 268, 20022-20030.
108. Mizwicki, M. T.; Norman, A. W. Two key proteins of the vitamin D endocrine system come into crystal clear focus: comparison of the X-ray structures of the nuclear receptor for 1alpha,25(OH)2 vitamin D3, the plasma vitamin D binding protein, and their ligands. J. Bone Miner. Res., 2003, 18, 795-806.
109. Rao, D. S.; Campbell, M. J.; Koeffler, H. P.; Ishizuka, S.; Uskokovic, M. R.; Spagnuolo, P.; Reddy, G. S. Metabolism of 1alpha,25-dihydroxyvitamin D(3) in human promyelocytic leukemia (HL-60) cells: in vitro biological activities of the natural metabolites of 1alpha,25-dihydroxyvitamin D(3) produced in HL- 60 cells. Steroids, 2001, 66, 423-431.
110. Ishizuka, S.; Sumitani, K.; Hiura, K.; Kawata, T.; Okawa, M.; Hakeda, Y.; Kumegawa, M. Biological activity assessment of 1 alpha,25-dihydroxyvitamin D3-26,23-lactone and its intermediate metabolites in vivo and in vitro. Endocrinology, 1990, 127, 695-701.
111. Norman, A. W.; Manchand, P. S.; Uskokovic, M. R.; Okamura, W. H.; Takeuchi, J. A.; Bishop, J. E.; Hisatake, J. I.; Koeffler, H. P.; Peleg, S. Characterization of a novel analogue of 1alpha,25(OH)(2)-vitamin D(3) with two side chains: interaction with its nuclear receptor and cellular actions. J. Med. Chem., 2000, 43, 2719-2730.
112. Peleg, S.; Sastry, M.; Collins, E. D.; Bishop, J. E.; Norman, A. W. Distinct conformational changes induced by 20-epi analogues of 1 alpha,25-dihydroxyvitamin D3 are associated with enhanced activation of the vitamin D receptor. J. Biol. Chem., 1995, 270, 10551-10558.
113. Binderup, L.; Latini, S.; Binderup, E.; Bretting, C.; Calverley, M.; Hansen, K. 20-epi-vitamin D3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem. Pharmacol., 1991, 42, 1569-1575.
114. Ishizuka, S.; Norman, A. W. The difference of biological activity among four diastereoisomers of 1 alpha,25-dihydroxychol- ecalciferol-26,23-lactone. J. Steroid Biochem., 1986, 25, 505-510.
115. Ciesielski, F.; Rochel, N.; Mitschler, A.; Kouzmenko, A.; Moras, D. Structural investigation of the ligand binding domain of the zebrafish VDR in complexes with 1alpha,25(OH)2D3 and Gemini: purification, crystallization and preliminary X-ray diffraction analysis. J. Steroid Biochem. Mol. Biol., 2004, 89-90, 55-59.
116. Tocchini-Valentini, G.; Rochel, N.; Wurtz, J. M.; Mitschler, A.; Moras, D. Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands. Proc. Natl. Acad. Sci. U. S. A, 2001, 98, 5491-5496.
117. Miura, D.; Manabe, K.; Ozono, K.; Saito, M.; Gao, Q.; Norman, A. W.; Ishizuka, S. Antagonistic action of novel 1alpha,25- dihydroxyvitamin D3-26, 23-lactone analogs on differentiation of human leukemia cells (HL-60) induced by 1alpha,25- dihydroxyvitamin D3. J. Biol. Chem., 1999, 274, 16392-16399.
118. Ozono, K.; Saito, M.; Miura, D.; Michigami, T.; Nakajima, S.; Ishizuka, S. Analysis of the molecular mechanism for the antagonistic action of a novel 1alpha,25-dihydroxyvitamin D(3) analogue toward vitamin D receptor function. J. Biol. Chem., 1999, 274, 32376-32381.
119. Toth, N.; Szabo, A.; Kacsala, P.; Heger, J.; Zador, E. 20- Hydroxyecdysone increases fiber size in a muscle-specific fashion in rat. Phytomedicine., 2008, 15, 691-698.
120. Lafont, R.; Dinan, L. Practical uses for ecdysteroids in mammals including humans: an update. J. Insect Sci., 2003, 3, 7.
121. Syrov, N. V.; Saatov, Z.; Sagdullaev, Sh. Sh.; Mamatkhanov, A. U. Study of the Structure-Anabolic Activity Relationship for Phytoecdysteroids Extracted from some Plants of Central Asia. Pharm. Chem. J., 2001, 35, 667-671.
122. Syrov, V. N. Comparative experimental investigations of the anabolic activity of ecdysteroids and steranabols. Pharm. Chem. J., 2000, 34, 193-197.
123. Syrov, V. N.; Khushbaktova, Z. A. Experimental study of pharmacotherapeutic effect of phytoecdisteroids and nerobol in toxic liver damage. Eksp. Klin. Farmakol., 2001, 64, 56-58.
124. Saatov, Z.; Agzamkhodzhaeva, D. A.; Syrov, V. N. Distribution of phytoecdysteroids in plants of Uzbekistan and the possibility of using drugs based on them in neurological practice. Chemistry of Natural Compounds, 1999, 35, 186-191.
125. Gorelick-Feldman, J.; Maclean, D.; Ilic, N.; Poulev, A.; Lila, M. A.; Cheng, D.; Raskin, I. Phytoecdysteroids increase protein synthesis in skeletal muscle cells. J. Agric. Food Chem., 2008, 56, 3532-3537.
126. Otaka, T.; Uchiyama, M.; Okui, S.; Takemoto, T.; Hikino, H. Stimulatory effect of insect-metamorphosing steroids from Achyranthes and Cyathula on protein synthesis in mouse liver. Chem. Pharm. Bull. (Tokyo), 1968, 16, 2426-2429.
127. Guttridge, D. C. Signaling pathways weigh in on decisions to make or break skeletal muscle. Curr. Opin. Clin. Nutr. Metab Care, 2004, 7, 443-450.
128. Syrov, V. N. Mechanism of the anabolic action of phytoecdister- oids in mammals. Nauchnye. Doki. Vyss. Shkoly. Biol. Nauki, 1984, 11, 16-20.
129. Whitehead, D. L. Steroids enhance shell regeneration in an aquatic gastropod (Biomphalaria glabrata). Comp. Biochem. Physiology C, 1977, 58, 137-41.
130. Kotsiuruba, A. V.; Akhmed, I.; Tarakanov, S. S; Kholodova, Iu. D. Mechanism of action of ecdysterone in chickens with D- hypovitaminosis. Early phase of effect. Ukr.Biokhim.Zh. 1993, 65, 83-90.
131. Kholodova, Iu. D.; Tugai, V. A.; Zimina, V. P. Effect of vitamin D3 and 20-hydroxyecdysone on the content of ATP, creatine phosphate, carnosine and Ca2+ in skeletal muscles. Ukr.Biokhim. Zh., 1997, 69, 3-9.
132. Kotsiuruba, A. V.; Bukhanevich, O. M.; Mehed', O. F.; Tarakanov, S. S.; Berdishev, A. H.; Tuhanova, A. V. The C(27)-steroid hormones ecdysterone and calcitriol activate the phosphoinositol cycle in its membrane phase. Ukr. Biokhim. Zh., 1999, 71, 27-32.
133. Kotsiuruba, A. V.; Bukhanevich, O. M.; Tarakanov, S. S.; Tuhanova, A. V.; Berdyshev, A. H.; Mehed', O. F. The C(27)-steroid hormones calcitriol and ecdysterone in the early phase of its action activates hydrolysis of phosphatidylcholines in target animal tissues. Ukr. Biokhim. Zh., 1998, 70, 37-44.
134. Kotsiuruba, A. V.; Bukhanevych, O. M.; Tarakanov, S. S.; Kholodova, I. Modulation of intracellular pools of cyclic purine nucleotides by biologically active oxysterol-ecdysterone and vitamin D3. Ukr. Biokhim. Zh., 1993, 65, 76-83.
135. Kotsiuruba, A. V.; Bukhanevich, O. M.; Tuhanova, A. V.; Tarakanov, S. S.; Berdyshev, A. H. Mechanisms of the early effect of biologically active hydroxysterols: calcitriol and ecdysterone. Modulation of systems which generate low molecular weight activators of guanylate cyclase. Ukr. Biokhim. Zh., 1995, 67, 58-64.
136. Kotsiuruba, A. V.; Bukhanevich, O. M.; Tuhanova, A. V.; Tarakanov, S. S. Mechanisms of the early effect of biologically active hydroxysterols: calcitriol and ecdysterone. Modulation of intracellular pools of arachidonic acid and products of its oxidative metabolism. Ukr. Biokhim. Zh., 1995, 67, 45-52.
137. Sahach, V. F.; Korkach, Iu. P.; Kotsiuruba, A. V.; Rudyk, O. V.; Vavilova, H. L. Mitochondrial permeability transition pore opening inhibition by ecdysterone in heart mitochondria of aging rats. Fiziol. Zh., 2008, 54, 3-10.
138. Kuzmenko, A. I.; Morozova, R. P.; Nikolenko, I. A.; Korniets, G. V.; Kholodova, Yu. D. Effects of vitamin D3 and ecdysterone on free-radical lipid peroxidation. Biokhimiya (Moscow), 1997, 62, 609-612.
139. Kuzmenko, A. I.; Morozova, R. P.; Nikolenko, I. A.; Korniets, G. V.; Kholodova, Yu. D. Effects of vitamin D3 and ecdysterone on free-radical lipid peroxidation. Biokhimiya (Moscow,) 1997, 62, 609-612.
140. Kuzmenko, A. I.; Morozonv, R. P.; Nikolenko, I. A.; Donchenko, G. V. Vitamin D3 and 20-hydroxyecdysone - inhibiting agents of lipid free radical oxidation in D-hypovitaminosis. Ukr. Biokhim. Zh., 2001, 73, 44-50.
141. Sahach, V. F.; Korkach, I.; Kotsiuruba, A. V.; Prysiazhna, O. D. The inhibition of oxidative and nitrosative stresses by ecdysterone as the mechanisms of its cardio- and vasoprotective action in experimental diabetes type I. Fiziol. Zh., 2008, 54, 46-54.
142. Levitsky, E. L.; Kholodova, Yu. D.; Gubski, Yu. I.; Primak, R. G.; Chabanny, V. N.; Kindruk, N. L.; Mozzhukhina, T. G.; Lenchevskaya, L. K.; Mironova, V. N. et al. Biochemical characteristics of rat liver fractionated chromatin under experimental D- hypovitaminosis and after treatment by steroidal préparations. Ukr. Biokhim. Zh., 1993, 65, 28-36.
143. Kaneki, M.; Shimizu, N.; Yamada, D.; Chang, K. Nitrosative stress and pathogenesis of insulin resistance. Antioxid. Redox. Signal., 2007, 9, 319-329.
144. Bonetto, A.; Penna, F.; Muscaritoli, M.; Minero, V. G.; Fanelli, F. R.; Baccino, F. M.; Costelli, P. Are antioxidants useful for treating skeletal muscle atrophy? Free Radic. Biol. Med., 2009, 47, 906-916.
145. Gupta, R.; Dixon, K. M.; Deo, S. S.; Holliday, C. J.; Slater, M.; Halliday, G. M.; Reeve, V. E.; Mason, R. S. Photoprotection by 1,25 dihydroxyvitamin D3 is associated with an increase in p53 and a decrease in nitric oxide products. J. Invest Dermatol., 2007, 127, 707-715.
146. Dixon, K. M.; Deo, S. S.; Norman, A. W.; Bishop, J. E.; Halliday, G. M.; Reeve, V. E.; Mason, R. S. In vivo relevance for photoprotection by the vitamin D rapid response pathway. J. Steroid Biochem. Mol. Biol., 2007, 103, 451-456.
147. Sato, Y.; Iwamoto, J.; Kanoko, T.; Satoh, K. Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc. Dis., 2005, 20, 187-192.
148. Norman, A. W. Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology, 2006, 147, 5542-5548.